Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Weight Control in Pediatric Patients on Atypical Antipsychotics
NCT00391261Phase 4Completed
- Sponsor
- Cambridge Health Alliance
- Start
- Jul 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of metformin, sponsored by Cambridge Health Alliance. Primary endpoints: Body Mass Index at 12 weeks and Body Weight at 12 weeks. Started Jul 2006; status: completed.
02
Drugs
metformin
Beyond the preview
Go deeper on NCT00391261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00391261.